Researchers find biologic process for warfarin API; EU manufacturers ask for climate reg relief

> Singapore reported 4.5% growth in pharmaceutical output last month after a 21.2% contraction in December. Report

> Researchers at the University of Georgia say they have developed a biological process to produce 4HC, which is important in producing warfarin and other anticoagulants. Report

> Can-Fite BioPharma says Japan has granted it a patent for its manufacturing process to make the API A3 adenosine receptor agonist IB-MECA for a new drug candidate. Report

> Precision instrument maker TSI has purchased the Raman spectroscopy technology from Enwave Optronics, for an undisclosed amount. Release

And Finally... A group of 137 EU manufacturers is calling on the government to rewrite emissions policies to prevent manufacturers from relocating abroad. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.